Therefore, ex vivo quantitative analysis of IFN-γ is a reliable predictor for the appropriate therapeutic response to the promising bivalent HPV vaccine immunotherapy in wart patients, although IL-4 analysis could be a reliable predictor for the unfavorable outcome when combined with IFN-γ analysis. This evidence concerns the gene IL4 and common wart.